Vioxx, the popular arthritis medication, has been pulled from the market by drug manufacturer Merck & Co. The company announced an immediate, voluntary, worldwide withdrawal of the drug after a three-year colon cancer study confirmed long-standing concerns the drug raises the risk of heart attack and stroke.
The over-the-counter drug Aleve, sold generically as naproxen, joins the list of recent painkillers facing federal scrutiny for potential heart risks. The National Institutes of Health has suspended an Alzheimer's prevention trial involving Aleve and Celebrex, because Aleve was shown to increase the risk of heart attacks or stroke by 50% among healthy elderly patients
A new warning is out about the popular arthritis drug Celebrex, saying it increased heart attacks in a recent study. This is the same class of drugs that contains Vioxx, which was pulled from the market due to an increased risk of heart attack and stroke, and Bextra, which had a heart warning added to its label this year.
Pfizer announced that it has suspended the use of Celebrex, the popular arthritis pain medication, in a cancer-prevention study because those who took Celebrex had 2.5 times as many fatal and nonfatal heart attacks as those who did not take the drug. The company said that it has no plans to pull it from the market until it studies the data.